<DOC>
	<DOCNO>NCT00174408</DOCNO>
	<brief_summary>The primary objective evaluate , Genotonorm ( Genotropin ) increase linear growth short child bear SGA . Safety drug main objective well . The growth promote effect two different dosage compare . The effect long-term treatment final height evaluate ( accord several amendment )</brief_summary>
	<brief_title>Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age</brief_title>
	<detailed_description />
	<mesh_term>Growth Disorders</mesh_term>
	<criteria>Birth length 2 SD Height start 2 Sd Any endocrine chronic disease Any known syndrome short stature</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>